Clinical Trial

Prophylactic Intravenous Calcium Gluconate to Decrease Blood Loss at Time of Cesarean Delivery in Pregnant Patients at High Risk for Uterine Atony

Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
This research study is being done to learn what effect a single dose of calcium gluconate will have on blood loss at the time of cesarean delivery in pregnancy patients at high risk for uterine atony.
Protocol Amendment History 2 changes
notable Primary completion pushed: 2026-07 -> 2026-10 2026-07-25
minor Completion pushed: 2026-08 -> 2026-12 2026-07-25
Trial Details
NCT Number NCT07217899
Lead Sponsor University of Michigan
Conditions Blood Loss, Surgical, Blood Loss, Postoperative, Uterine Atony
Enrollment 140 participants
Start Date 2025-10-20
Primary Completion 2026-10 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2026-07-24